Oxford Nanopore Technologies (LON:ONT) Price Target Raised to GBX 225 at Deutsche Bank Aktiengesellschaft

Oxford Nanopore Technologies (LON:ONT) had its price target raised by Deutsche Bank Aktiengesellschaft from GBX 210 to GBX 225 in a research report report published on Thursday, Marketbeat Ratings reports. The firm currently has a buy rating on the stock.

Several other equities analysts have also recently commented on ONT. Peel Hunt reissued a “hold” rating and set a GBX 153 target price on shares of Oxford Nanopore Technologies in a research report on Friday, December 5th. Royal Bank Of Canada increased their price target on Oxford Nanopore Technologies from GBX 280 to GBX 300 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 250 price objective on shares of Oxford Nanopore Technologies in a research report on Monday, January 12th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Oxford Nanopore Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 233.60.

Oxford Nanopore Technologies Stock Up 7.5%

Oxford Nanopore Technologies stock opened at GBX 172.90 on Thursday. Oxford Nanopore Technologies has a fifty-two week low of GBX 88.60 and a fifty-two week high of GBX 224.80. The company has a debt-to-equity ratio of 8.07, a quick ratio of 6.01 and a current ratio of 4.45. The firm’s 50-day simple moving average is GBX 135.06 and its 200 day simple moving average is GBX 156.08. The stock has a market cap of £1.67 billion, a PE ratio of -11.68 and a beta of 0.80.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.